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ADAM17-Mediated Processing of TNF-a Expressed by
Antiviral Effector CD8+ T Cells Is Required for Severe
T-Cell-Mediated Lung Injury
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Abstract
Influenza infection in humans evokes a potent CD8+ T-cell response, which is important for clearance of the virus but may
also exacerbate pulmonary pathology. We have previously shown in mice that CD8+ T-cell expression of TNF-a is required
for severe and lethal lung injury following recognition of an influenza antigen expressed by alveolar epithelial cells. Since
TNF-a is first expressed as a transmembrane protein that is then proteolytically processed to release a soluble form, we
sought to characterize the role of TNF-a processing in CD8+ T-cell-mediated injury. In this study we observed that inhibition
of ADAM17-mediated processing of TNF-a by CD8+ T cells significantly attenuated the diffuse alveolar damage that occurs
after T-cell transfer, resulting in enhanced survival. This was due in part to diminished chemokine expression, as TNF-a
processing was required for lung epithelial cell expression of CXCL2 and the subsequent inflammatory infiltration. We
confirmed the importance of CXCL2 expression in acute lung injury by transferring influenza-specific CD8+ T cells into
transgenic mice lacking CXCR2. These mice exhibited reduced airway infiltration, attenuated lung injury, and enhanced
survival. Theses studies describe a critical role for TNF-a processing by CD8+ T cells in the initiation and severity of acute
lung injury, which may have important implications for limiting immunopathology during influenza infection and other
human infectious or inflammatory diseases.
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(HA) of A/Japan/57 H2N2 influenza A virus is expressed in
alveolar type II epithelial cells under the control of the surfactant
protein C (SPC) promoter. Lung injury in these SPC-HA
transgenic mice is induced by adoptive transfer of HA-specific
CD8+ T cells, which recognize an antigen corresponding to amino
acids 210–219 of HA [6]. The pathology mediated by HA-specific
CD8+ T cells in this system is severe, often lethal (depending upon
the number of T cells transferred), restricted to the lung and
requires expression of TNF-a by the transferred CD8+ T cells
[7,8]. Transfer of TNF-deficient HA-specific CD8+ T cells induces
minimal lung injury compared to transfer of HA-specific TNFproducing CD8+ T cells [7]. Consistent with a role of TNF-a in
inducing lung injury, SPC-HA transgenic mice deficient in either
TNF receptor 1 or TNF receptor 2 demonstrate significant
attenuation of lung injury following HA-specific CD8+ T-cell
transfer [7,9]. Furthermore, blockade of the inhibitory receptor
CD94/NKG2A expressed on activated CD8+ T cells results in
increased TNF-a production by the T cells and enhanced lung
injury [10].
The pathology mediated by TNF-a in our model is mediated to
a considerable degree by the induction of alveolar epithelial cell
chemokines and the subsequent cellular infiltration [8]. TNF-a,

Introduction
Clinical and experimental infection with influenza A virus may
result in considerable lung pathology and respiratory dysfunction.
While direct viral cytopathic effects can contribute to this injury, it
has been postulated that an excessive or dysregulated host immune
response mediates at least some of this pathology [1,2]. CD8+ T
cells play a critical role in the resolution and clearance of virus
during influenza infection [3,4]. However, there is also evidence
that CD8+ T cells may contribute to immunopathology as mice
deficient in T cells have significant delays in morbidity and
mortality following influenza infection [5]. CD8+ T cells likely
contribute directly to injury through cytolytic functions or
indirectly through production of cytokines, such as IFN-c and
TNF-a, but it is difficult to separate the effector functions that are
essential for viral clearance from those that contribute to
immunopathology.
To understand the specific contribution of CD8+ T cells to
immunopathology during influenza infection, our laboratory has
used a transgenic mouse to model influenza pneumonia, while
eliminating the complicating variable of direct effects of the virus
infection itself. In this model, the gene encoding the hemagglutinin
PLOS ONE | www.plosone.org
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Care and Use Committee (IACUC) at the Geisel School of
Medicine at Dartmouth College. In accordance with our IACUC
approved protocol, mice were euthanized via CO2 inhalation
under anesthesia or anesthesia overdose and exsanguination. A
composite endpoint was used as a surrogate for survival and mice
were sacrificed, as above, either after losing $ 20% of the initial
body weight, or other signs of severe illness, such as huddling and
piloerection.

signaling through the MAPK/ERK pathway, stimulated alveolar
epithelial cells to produce CCL2 and CXCL2, chemoattractant
molecules for macrophages and neutrophils, respectively [11].
Chemokine expression contributes to the progressive massive
recruitment of host neutrophils and macrophages into the lung,
that correlates with severe diffuse alveolar damage [12]. Consistent
with these findings, neutralization of CCL2 results in significantly
reduced parenchymal cellular infiltration in SPC-HA transgenic
mice following HA-specific CD8+ T-cell transfer [8]. Thus, CD8+
T cells can indirectly mediate immunopathology in a transgenic
mouse model of influenza infection by producing TNF-a upon
specific antigen recognition that results in alveolar epithelial cell
chemokine production and the subsequent cellular infiltration and
lung injury.
Several cell types, including macrophages, T cells, and NK cells
express TNF-a. It is expressed as a transmembrane protein
(tmTNF-a), which is subsequently released from the membrane as
a soluble protein (sTNF-a) by a proteolytic processing event
known as ectodomain shedding [13,14]. tmTNF-a and sTNF-a
have been shown to have distinct and overlapping biological
functions. For example, exclusive expression of non-cleavable
tmTNF-a in mouse models of septic shock renders mice resistant
to deleterious effects attributable to sTNF-a [15,16]. However,
tmTNF-a has been shown to provide a level of protection similar
to sTNF-a during certain types of infection [15–18]. These studies
suggest that sTNF-a and tmTNF-a mediate many of the
deleterious and protective effects of TNF-a signaling, respectively.
ADAM17 (A disintegrin and metalloproteinase), also known as
TNF-a converting enzyme (TACE), was identified as the primary
protease responsible for proteolytic processing of TNF-a [19,20].
ADAM17 processing of TNF-a by either leukocytes or endothelial
cells has been implicated in mediating inflammation during acute
lung injury [21,22]. However, examination of the role of
ADAM17 specifically in CD8+ T-cell effector function has been
subject to limited investigation as deletion of the zinc catalytic
domain of ADAM17 results in perinatal lethality [23]. Therefore,
it remains unknown whether ADAM17 is responsible for
processing TNF-a by effector CD8+ T cells, and whether
proteolytic processing of tmTNF-a to sTNF-a by ADAM17 is
required for severe T-cell-mediated immunopathology.
This study addresses the capacity of CD8+ T-cell expression of
sTNF-a and tmTNF-a to initiate immunopathology in a
transgenic mouse model of influenza infection. Using HA-specific
CD8+ T cells deficient in ADAM17 activity or exclusively
expressing non-cleavable tmTNF-a, we have demonstrated that
ADAM17 was required for severe and lethal lung injury.
However, ADAM17-deficiency did not impair CD8+ T-cell
protection to an otherwise lethal challenge of influenza virus.
Furthermore, sTNF-a, but not tmTNF-a, induced alveolar
epithelial cell production of CXCL2 and the subsequent
neutrophil infiltration. Consistent with these results, SPC-HA
transgenic mice lacking CXCR2, the receptor for CXCL2,
exhibited greatly reduced airway cellular infiltration and mortality
following transfer of CD8+ T cells. Together, these results suggest
that proteolytic processing of TNF-a by ADAM17 on CD8+ T
cells is a critical event in CD8+ T-cell-mediated lung injury.

Mice
Seven-week-old female C57BL/6, Balb/c, TNF2/2,
CXCR22/2, and Rag12/2 mice were purchased from Jackson
Laboratories (Bar Harbor, ME). SPC-HA transgenic mice (H-2d),
in the Balb/c and C57BL/6 genetic background, expressing the
full-length A/Japan/57 influenza HA in the distal lung were
previously described and used at 7 to 12 weeks of age [6].
ADAM17+/DZn mice expressing a deletion in the zinc catalytic
domain of ADAM17, in the C57BL/6 genetic background, were
kindly provided by Dr. Carl Blobel, and were bred with B10.D2
(H-2d haplotype). Mice expressing a deletion of the first twelve
amino acids of the TNF-a juxtamembrane extracellular domain
(DTNFD1-12) were kindly provided by Dr. George Kollias [16].
These mice were bred with TNF2/2 mice which had been crossed
with transgenic mice expressing ectopic H-2Kd to generate mice in
the C57BL/6 background that exclusively express non-cleavable
tmTNF-a (referred to from here on as tmTNF) [7]. CXCR22/2
mice expressing the HA transgene were generated by breeding
CXCR22/2 mice with SPC-HA transgenic mice.

Generation of ADAM17-deficient CD8+ T cells
ADAM17+/DZn pregnant female mice were sacrificed 16-18
days after the initiation of pregnancy. Since ADAM17DZn/DZn
(referred to from here on as ADAM172/2) mice die early in the
perinatal period, homozygous knockout pups were identified by
their characteristic "open-eye" phenotype at this stage of
development [23], and fetal livers were harvested from ADAM172/2 pups (and WT controls). Fetal liver chimeras were
developed by producing a single-cell suspension from these livers
and injecting them via the tail vein into sub-lethally irradiated
Rag12/2 mice. Six to eight weeks after transfer, immune
reconstitution was confirmed, and then mice were anesthetized
and intranasally infected with a sub-lethal dose of A/Japan/57
influenza virus. Three weeks later mice were sacrificed, spleens
were harvested and a single-cell suspension was prepared.
Splenocytes were stimulated by co-culture with irradiated Balb/c
splenocytes and pulsed with HA2102219 peptide (a Kd-restricted
epitope of the A/Japan/57 HA) to expand and generate a bulk
culture of HA-specific CD8+ T cells. Cells were maintained at
37uC, 5% CO2 in fresh Iscove’s complete media supplemented
with 40 IU/ml human IL-2, and restimulated in vitro biweekly to
expand large numbers of CD8+ T cells in preparation for adoptive
transfer, as previously described [6,24].

Protection against lethal influenza infection
C57BL/6 mice received 10 7 WT or ADAM172/2 H-2b CD8+
T cells specific for the H-2Db-restricted NP3662374 nucleoprotein
epitope of A/PR/8/34 influenza A virus by tail vein injection.
Shortly after T-cell transfer, mice were anesthetized and
intranasally challenged with 10LD50 A/PR/8/34 influenza A
virus. Mice were monitored daily for weight loss and survival.

Methods
Ethics statement
All mice were treated humanely and all studies were conducted
in accordance with guidelines approved by the Association for
Assessment and Accreditation of Laboratory Animal Care
(AALAC) using a protocol approved by the Institutional Animal
PLOS ONE | www.plosone.org
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Adoptive transfer

Flow cytometry

HA-specific CD8+ T cells were removed from culture 5 days
after in vitro restimulation and expansion, and subjected to
histopaque density centrifugation to remove irradiated stimulator
cells. 56106-107 HA-specific cells were adoptively transferred into
SPC-HA transgenic mice by tail vein injection. In some
experiments, HA-specific CD8+ T cells were labeled with
carboxyfluorescein succinimidyl ester (CFSE) prior to transfer to
monitor T-cell trafficking to the lung. Mice were monitored daily
for weight change and survival. Peripheral oxygen saturation was
measured using the MouseOx system (Starr Life Sciences Corp.,
Allison Park, PA) according to the manufacturer’s protocol.
Measurements of conscious mice were taken before and after Tcell transfer.

The following anti-mouse monoclonal antibodies were purchased from Biolegend: FITC-CD8 (53-6.7), PerCP/Cy5.5-TNFa (MAb11), and APC-IFN-c (XMG1.2). Anti-CD16/32 was
purchased from DartLab. For intracellular cytokine staining,
HA-specific CD8+ T cells were stimulated with HA2102219 peptide
in the presence of brefeldin A (10mg/ml) and maintained in
brefeldin A until fixation. Cells were then blocked with antiCD16/32 and stained with antibodies specific for CD8, TNF-a,
and IFN-c as previously described [10], and analyzed with a
FACS Calibur cytometer (BD Biosciences, San Jose, CA) and
FlowJo software (Tree Star, Ashland, OR).

Statistical analyses
Statistical analysis was performed with GraphPad Prism
(GraphPad Software Inc., La Jolla, CA) using a two-tailed
unpaired t-test with 95% confidence interval and differences in
survival after influenza challenge or adoptive transfer experiments
were determined by log-rank analysis of Mantel-Cox data.

Bronchoalveolar lavage (BAL)
At appropriate time points, mice were euthanized and tracheas
were dissected and cannulated. Lungs were lavaged with 1 mL
PBS as previously described [25]. The recovered fluid was
centrifuged and the supernatant was frozen for later analysis of
cytokines and chemokines. Cells were counted on a hemocytometer with trypan blue exclusion to determine the total number of
viable cells. To determine the cell populations present, cytospin
preparations were stained using the Protocol Hema 3 stain set
(Fisher, Houston, TX). Neutrophils and macrophages present in
BAL samples were enumerated by morphological analysis of 100
cells per cytospin preparation. The absolute number of neutrophils
and macrophages was determined by multiplying the percent of
cells in cytospin preparations by the total number of viable cells
recovered from BAL.

Results
Proteolytic processing of TNF-a by CD8+ T cells is
required for lung epithelial cell expression of CXCL2 in
vitro
We had previously shown that following recognition of an
antigen expressed on lung epithelial cells in vivo, expression of
TNF-a by CD8+ T cells was required to induce lung epithelial cell
expression of CCL2 and CXCL2 [27]. We first wanted to examine
whether sTNF-a or tmTNF-a expression by antigen-specific
CD8+ T cells was required for lung epithelial cell expression of
CCL2 and CXCL2. To test this, we used an in vitro system that
reflects the interaction of CD8+ T cells with lung epithelial cells
that occurs in vivo. MLE-Kd cells were pulsed with HA2102219
peptide and co-cultured with HA-specific CD8+ T cells that
exclusively expressed non-cleavable tmTNF-a (tmTNF) and
chemokine production by MLE-Kd cells was examined. Upon
specific antigen recognition in vitro, tmTNF CD8+ T cells did not
produce sTNF-a (Figure 1A). However, TNF-a production was
not impaired in these cells as activated tmTNF CD8+ T cells
expressed similar total levels of TNF-a protein compared to WT
cells (Figure 1B). Next, we examined whether tmTNF-a could
induce lung epithelial cell chemokine production. As expected,
TNF2/2 CD8+ T cells did not induce lung epithelial cell
expression of CCL2 and CXCL2 (Figures 1C, 1D). The addition
of exogenous sTNF-a to co-culture of MLE-Kd cells and activated
TNF2/2 CD8+ T cells induced MLE-Kd production of CCL2 and
CXCL2 indicating that sTNF-a was sufficient to induce expression of these chemokines (Figures 1C, 1D). Interestingly, activated
tmTNF CD8+ T cells were capable of inducing MLE-Kd cell
expression of CCL2, albeit at a significantly lower level than that
induced by activated WT cells (Figure 1C). However, tmTNF
CD8+ T cells did not induce MLE-Kd cell expression of CXCL2
(Figure 1D). Taken together, these data indicate that proteolytic
processing of TNF-a by CD8+ T cells is required to induce lung
epithelial cell expression of CXCL2, but not CCL2, in vitro.

Lung histology
On day 5 after adoptive transfer of 56106 HA-specific CD8+ T
cells, SPC-HA transgenic mice were euthanized. The trachea was
dissected and cannulated and the lungs were inflated with 0.5%
low melting point agarose in PBS at 25uC as previously described
[26]. Inflated lungs were fixed in formalin, sectioned, and stained
with hematoxylin and eosin.

Mouse lung epithelial cell culture
Mouse alveolar epithelial-derived cells (MLE-15), stably transfected with H-2Kd (MLE-Kd) were maintained as previously
described [24]. Cells were plated and allowed to adhere overnight.
The next day, cells were pulsed with HA2102219 peptide and excess
peptide was removed by washing. Peptide-pulsed MLE-Kd cells
were co-cultured with HA-specific CD8+ T cells for 5 hours.
Supernatants were removed and stored for analysis of cytokine
and chemokine production. In some experiments, 10 ng/mL
recombinant mouse TNF-a (Biolegend, San Diego, CA) was
added to the culture media.

Cytokine and chemokine profile analysis
Cytokine and chemokine expression in BAL fluid recovered
after CD8+ T-cell transfer was determined by Millipore Mouse 32plex Luminex assay performed by DartLab (Lebanon, NH).
ELISA was used to determine the albumin concentration in BAL
samples (Bethyl Laboratories, Montgomery, TX). In vitro production of TNF-a, CCL2, and CXCL2 in co-culture experiments was
determined using ELISA kits from Biolegend (San Diego, CA) and
R&D Systems (Minneapolis, MN).

PLOS ONE | www.plosone.org

Proteolytic processing of TNF-a is required for CD8+ Tcell-mediated lung injury
After demonstrating that proteolytic processing of TNF-a by
CD8+ T cells was required for alveolar epithelial cell production of
CXCL2 in vitro, we next examined whether proteolytic processing
of TNF-a on the surface of activated CD8+ T cells was required
3
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Figure 1. CD8+ T-cell processing of TNF-a is required for lung epithelial cell expression of CXCL2. MLE-Kd cells were pulsed with
HA2102219 peptide and co-cultured with HA-specific CD8+ T cells for 5 hours. In some experiments, recombinant mouse TNF-a was added to the
culture supernatant. Cell-free supernatant was analyzed for expression of (A) TNF-a, (C) CCL2, and (D) CXCL2 by ELISA. (B) Alternatively, total TNF-a
production by HA-specific CD8+ T cells after PMA/ionomycin stimulation with protease inhibitor and detergent solubilization was measured by ELISA.
Data represents mean 6 standard deviation. Data are representative of three independent experiments with each condition conducted in triplicate.
*P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0079340.g001

for CD8+ T-cell-mediated lung injury in vivo in a non-infectious
transgenic mouse model of influenza infection. In this model, we
adoptively transferred HA-specific tmTNF CD8+ T cells into
SPC-HA transgenic mice. Recipients of tmTNF CD8+ T cells
exhibited no mortality in contrast to WT recipients, which
exhibited progressive morbidity and were sacrificed 4 days after
transfer (Figure 2A). In a separate set of experiments using a lower
number of transferred T cells, we observed extensive infiltration of
the airspaces and septae with morphologic evidence of diffuse
alveolar damage, edema and hemorrhage in recipients of WT
CD8+ T cells 5 days after transfer (Figure 2B). In striking contrast,
there was minimal infiltration of the alveolar airspace and
abrogation of interstitial infiltration and septal congestion in
recipients of tmTNF CD8+ T cells (Figure 2C). Consistent with the
apparent absence of significant alveolar injury in tmTNF CD8+ Tcell recipients, gas exchange as measured by carbon monoxide
uptake (a surrogate for oxygen diffusing capacity [6]) was
significantly greater 3 days after transfer compared to WT
recipients (Figure 2D). To understand the mechanisms underlying
the milder lung injury resulting solely from the CD8+ T-cell TNFa processing defect, lungs were harvested on sequential days after
transfer and digested to analyze cell populations and chemokine
expression. Total cell counts were consistently lower in tmTNF
CD8+ T-cell recipients. In addition, there was a significant
reduction in the percentage of neutrophils in the lungs of tmTNF
CD8+ T-cell recipients (Figure 2E). We examined whether a
PLOS ONE | www.plosone.org

decrease in CXCL2, a neutrophil chemoattractant, was responsible for the reduced neutrophil influx, as its expression in lung
epithelial cells was not induced by tmTNF-a expressed on
activated CD8+ T cells in vitro (Figure 1D). We found that there
was a significant reduction in CXCL2 in the lungs of tmTNF
CD8+ T-cell recipients 24 hours after transfer that remained
significantly lower 3 days after transfer compared to recipients of
WT cells (Figure 2F). Thus, CD8+ T-cell processing of TNF-a
appears critical for neutrophil influx and acute lung injury,
presumably through alveolar epithelial cell expression of neutrophil chemokines, including CXCL2.

CD8+ T-cell-mediated lung injury depends in part on
CXCR2 signaling
To investigate further the role of CXCL2 in mediating
neutrophil infiltration into the airways and diffuse alveolar
damage, we generated SPC-HA transgenic mice deficient in
CXCR2, the receptor for CXCL2. Adoptive transfer of HAspecific WT CD8+ T cells into CXCR22/2 SPC-HA transgenic
mice resulted in significantly reduced mortality in contrast to WT
SPC-HA transgenic animals, which exhibited progressive morbidity and eventual death of all the animals in the experiment by day
8 (Figure 3A). HA-specific WT CD8+ T-cell transfer into
CXCR22/2 SPC-HA transgenic recipients resulted in milder
lung injury as shown in figures 3B and 3C. Transfer of HA-specific

4
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Figure 2. Processing of TNF-a by CD8+ T cells is required for severe and lethal lung injury. SPC-HA transgenic mice received WT or tmTNF
HA-specific CD8+ T cells via tail vein injection. (A) Survival of mice after transfer of 107 T cells was monitored and a significant difference in survival
(P,0.05) was observed. Representative H&E stained lung sections from SPC-HA transgenic mice harvested 5 days after transfer of 56106 (B) WT or (C)
tmTNF CD8+ T cells shown at 10x magnification with 40x inset. (D) Carbon monoxide uptake was measured to assess lung function. (E) Percentage of
neutrophils in whole lung homogenates was determined by morphological analysis of cells after staining cytospin preparations. (F) ELISA was used to
assay CXCL2 expression in cell-free whole lung homogenates. Data represent mean 6 standard deviation. Data are representative of at least two
independent experiments with 3-4 mice per group. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0079340.g002

WT CD8+ T cells into WT SPC-HA transgenic recipients resulted
in extensive mononuclear cell infiltration and diffuse alveolar
damage with edema and hemorrhage 5 days after transfer (Figure
3B). However, there was a milder pattern of injury with
diminished cellular infiltration of the alveolar airspaces of
CXCR22/2 SPC-HA transgenic recipients (Figure 3C). The
milder injury we observed in CXCR22/2 SPC-HA-transgenic
animals was consistent with the increased survival of these animals
following HA-specific WT CD8+ T-cell transfer, indicating that
CXCR2 signaling is important for severe acute lung injury
following CD8+ T-cell alveolar antigen recognition.

T cells stimulated with HA2102219 peptide was significantly
reduced compared to stimulated WT CD8+ cells indicating that
ADAM17 was the principal protease for TNF-a processing by
CD8+ T cells (Figure 4A). Impaired TNF-a processing by
ADAM172/2 CD8+ T cells resulted in a significant enhancement
in surface expression of tmTNF-a (Figure 4B). However,
ADAM17-deficiency did not impair total TNF-a production, as
ADAM172/2 CD8+ T cells expressed similar total levels of TNFa protein compared to WT CD8+ T cells when protein secretion
was blocked (Figure 4C). Also, ADAM172/2 CD8+ T cells were
not deficient in IFN-c production or secretion, suggesting that
ADAM17-deficiency did not impair other effector functions
(Figures 4C, 4D). Importantly, the ability to protect from an
otherwise lethal influenza infection was not impaired by
ADAM17-deficiency, as adoptive transfer of virus-specific ADAM172/2 CD8+ T cells into mice infected with a lethal dose of
influenza virus provided complete protection against death (Figure
4E). This indicates that ADAM172/2 CD8+ T cells can traffic to
the lung, where they appropriately recognize viral antigen, and
express effector activities required for protection from lethal viral
infection. Thus, ADAM17 is required for proteolytic processing
and release of sTNF-a by CD8+ T cells, but it is not required for
other CD8+ T-cell effector functions in virus infection.

ADAM17 is required for proteolytic processing of TNF-a
by CD8+ T cells
Since proteolytic processing of TNF-a by CD8+ T cells was a
critical event in CD8+ T-cell-mediated lung injury, we investigated
the cellular mechanisms regulating TNF-a processing by CD8+ T
cells. Consistent with our previous observations, a broad-spectrum
protease inhibitor blocked sTNF-a production following
HA2102219 peptide-stimulation (Figure 4A) [9]. ADAM17 has
been identified as the protease responsible for proteolytic
processing of TNF-a in a number of cell types [19]. However,
the role of ADAM17 in CD8+ T-cell processing of TNF-a and
other effector functions is unknown. To examine the role of
ADAM17 in CD8+ T-cell function, we generated HA-specific
ADAM172/2 CD8+ T cells from Rag12/2 mice reconstituted
with ADAM172/2 fetal liver cells and immunized with influenza
virus. Production of sTNF-a by HA-specific ADAM172/2 CD8+
PLOS ONE | www.plosone.org

Expression of ADAM17 on transferred CD8+ T cells is
required for severe and lethal lung injury
After confirming ADAM17 as the protease responsible for
processing TNF-a by CD8+ T cells, we investigated whether a lack
5
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Figure 3. CD8+ T-cell-mediated acute lung injury depends in part on CXCR2 signaling. WT and CXCR22/2 SPC-HA transgenic mice
received 56106 WT HA-specific CD8+ T cells via tail vein injection. (A) Survival of mice after T-cell transfer was monitored daily and a striking difference
in survival (P,0.001) was observed. Representative H&E stained lung sections from (B) WT-HA or (C) CXCR22/2-HA mice harvested 5 days after
transfer of WT HA-specific CD8+ T cells shown at 10x magnification with 40x inset. Data are representative of at least two independent experiments
with 4-5 mice per group.
doi:10.1371/journal.pone.0079340.g003

of ADAM17 on CD8+ T cells modulated lung injury in our noninfectious, SPC-HA transgenic mouse model of influenza infection
by adoptively transferring HA-specific ADAM172/2 CD8+ T cells
into SPC-HA transgenic mice. Recipients of ADAM172/2 CD8+
T cells exhibited no mortality, in contrast to WT recipients, which
exhibited progressive morbidity and were sacrificed 4 days after
transfer (Figure 5A). Histologically, recipients of WT CD8+ T cells
exhibited extensive alveolar airspace and interstitial mononuclear
cell infiltration with widespread alveolar damage (Figure 5B). In
contrast, ADAM172/2 CD8+ T-cell recipients had substantially
milder inflammatory cell infiltration with limited tissue damage
(Figure 5C). This histological observation of milder lung injury
prompted our measurement of albumin leakage into the airways,
and we found that albumin in the airways of ADAM172/2 CD8+
T-cell recipients was significantly decreased 24 hours and 3 days
after T-cell transfer compared to WT recipients (Figure 5D). This
suggests that there was substantially less damage to the alveolarcapillary barrier in recipients of ADAM172/2 CD8+ T cells as
presence of albumin is a marker for vascular leakage. Consistent
with the reduced lung damage, no significant decrease in
peripheral oxygen saturation was observed following transfer of
ADAM172/2 CD8+ T cells compared to pre-transfer measurements (Figure 5E). In contrast, there was a decrease in peripheral
oxygen saturation 3 days after transfer of WT CD8+ T cells and
this was markedly lower than the peripheral oxygen saturation
observed in recipients of ADAM172/2 CD8+ T cells 3 days after
transfer (Figure 5E). Taken together, these results indicate that
ADAM17 activity on transferred CD8+ T cells is critical for the
initiation of severe and lethal lung injury in a transgenic mouse
model of influenza pneumonia.

SPC-HA transgenic mice 24 hours or 3 days after T-cell transfer
and measured sTNF-a protein expression by ELISA. Following
antigen recognition in vivo, WT CD8+ T cells were activated to
produce and release sTNF-a, which was confirmed by the
substantial amount of sTNF-a present in the airways of WT
recipients (Figure 6A). In contrast, there was a significant
reduction in the levels of sTNF-a on both days examined in
recipients of ADAM172/2 CD8+ T cells (Figure 6A). These results
are consistent with the impaired processing of TNF-a we observe
from ADAM172/2 CD8+ T cells activated in vitro (Figure 4A).
Furthermore, the levels of IFN-c in the airways of WT and
ADAM172/2 CD8+ T-cell recipients were similar (Figure 6B).
These results recapitulate the expression patterns of IFN-c
observed after activation of WT and ADAM172/2 CD8+ T cells
in vitro (Figure 4D). To confirm that similar numbers of WT and
ADAM172/2 CD8+ T cells trafficked to the lungs of SPC-HA
transgenic mice, we labeled CD8+ T cells with CFSE prior to
transfer and recovered cells from the lung 24 hours after T-cell
transfer. We observed similar numbers of transferred cells in the
airways and lungs of WT or ADAM172/2 CD8+ T-cell recipients
24 hours after transfer indicating that the reduced levels of sTNF-a
in the airways of ADAM172/2 CD8+ T-cell recipients was not
due to failure of the transferred cells to traffic to the lung (Figures
6C, 6D). Therefore, these data strongly suggest that both WT and
ADAM172/2 CD8+ T cells are capable of trafficking to the lung
and interacting with HA antigen expressed by the alveolar
epithelium. Moreover, the milder lung injury observed in
ADAM172/2 CD8+ T-cell recipients is primarily the result of
impaired proteolytic processing of TNF-a.

Expression of ADAM17 is required for production of
sTNF-a by transferred CD8+ T cells in vivo

Expression of ADAM17 on CD8+ T cells is required for
enhanced pulmonary infiltration of macrophages and
neutrophils

Since we observed impaired sTNF-a production following
antigen stimulation of ADAM172/2 CD8+ T cells in vitro and
SPC-HA transgenic recipients of HA-specific CD8+ T cells that
exclusively express non-cleavable tmTNF-a exhibit substantially
milder lung injury, we speculated that the milder injury in
recipients of ADAM172/2 CD8+ T cells was due to impaired
proteolytic processing of TNF-a by the transferred cells following
antigen recognition in vivo. To assess whether ADAM17-deficiency
on transferred HA-specific CD8+ T cells resulted in less
production of sTNF-a, we recovered cell-free BAL fluid from

To understand the mechanisms underlying the milder lung
injury resulting solely from the defect in TNF-a processing by
ADAM172/2 CD8+ T cells, we wanted to quantify the effects that
transfer of ADAM172/2 CD8+ T cells had on the pulmonary
infiltration of specific inflammatory cells. We recovered cells from
BAL of SPC-HA transgenic recipients at one and three days after
HA-specific CD8+ T-cell transfer and determined the percent and
absolute numbers of macrophages and neutrophils from morphological analysis of cytospin preparations. There was a reduction in
the total number of cells recovered from the BAL of ADAM172/2
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Figure 4. ADAM17 is required for proteolytic processing of TNF-a by CD8+ T cells. WT or ADAM172/2 HA-specific CD8+ T cells were
stimulated with HA2102219 peptide for 5 hours. (A) ELISA was used to assess soluble TNF-a production. In some experiments a TNF-a protease
inhibitor (TAPI) was added at a final concentration of 50 mm. (B) Surface expression of tmTNF-a was determined by flow cytometric analysis (Ig
control-Gray shading, WT-Dashed line, ADAM172/2-Solid line). (C) Total intracellular production of TNF-a and IFN-c was determined by flow
cytometric analysis of T cells stimulated in the presence of brefeldin A (WT-Left, ADAM172/2-Right). (D) ELISA was used to measure IFN-c production.
Data represent mean 6 standard deviation. Data are representative of three independent experiments with each condition conducted in triplicate.
***P,0.001. (E) Survival of mice receiving a lethal dose of influenza A/PR/8/34 virus and media or 107 NP3662374-specific ADAM172/2 CD8+ T cells was
monitored daily and a difference in survival (P,0.05) was observed. Data are representative of two independent experiments using 4 mice per group.
doi:10.1371/journal.pone.0079340.g004

CD8+ T-cell recipients on both days examined when compared to
recipients of WT cells (Figure 7A). We found a slight increase in
the percent of macrophages present in the airways of ADAM172/
2
CD8+ T-cell recipients 24 hours after T-cell transfer (Figure 7B).
However, there was a reduction in the absolute number of
macrophages in ADAM172/2 CD8+ T-cell recipients on both one
and three days after transfer when compared to recipients of WT
cells (Figure 7C). There was also a reduction in the percentage of
neutrophils on both days examined in ADAM172/2 CD8+ T-cell
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recipients when compared to recipients of WT cells (Figure 7D).
This is similar to the attenuation of early neutrophil infiltration
that we observed in recipients of tmTNF CD8+ T cells,
highlighting a critical role for early neutrophil influx and acute
lung injury (Figure 2E). Additionally, there was a significant
reduction in the absolute number of neutrophils on both days
examined in ADAM172/2 CD8+ T-cell recipients compared to
recipients of WT cells (Figure 7E). These observations suggest that
CD8+ T-cell proteolytic processing of TNF-a by ADAM17
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Figure 5. ADAM17 expression on transferred CD8+ T cells is required for acute lung injury. SPC-HA transgenic mice received WT or
ADAM172/2 HA-specific CD8+ T cells via tail vein injection. (A) Survival of mice after transfer of 107 T cells was monitored and a difference in survival
(P,0.05) was observed. Representative H&E stained lung sections from SPC-HA transgenic mice harvested 5 days after transfer of 56106 (B) WT or (C)
ADAM172/2 CD8+ T cells shown at 10x magnification with 40x inset. (D) ELISA was used to assess the levels of albumin in cell-free BAL fluid after
transfer of 107 T cells. (E) Peripheral oxygen saturation was measured in mice before and after transfer of 107 T cells using the MouseOx System. Data
represent mean 6 standard deviation. Data are representative of at least three independent experiments with 3-4 mice per group. *P,0.05,
**P,0.01.
doi:10.1371/journal.pone.0079340.g005

alveolar type II epithelial cells isolated from SPC-HA transgenic
mice lacking TNFR1 following CD8+ T-cell transfer [7].
Interestingly, we observed a reduction in CXCL5 levels in the
airways of ADAM172/2 CD8+ T-cell recipients (Figure 8E). In
addition to CXCL2, CXCL5 is a neutrophil chemoattractant that
mediates its effects through CXCR2. Thus, blockade of both
CXCL2 and CXCL5 in CXCR22/2 SPC-HA transgenic mice
could contribute to the attenuated pulmonary cellular infiltrate we
observed. Furthermore, there was a decrease in the expression of
G-CSF, a growth factor important in neutrophil maturation, in
ADAM172/2 CD8+ T-cell recipients (Figure 8F). Using SPC-HA
transgenic mice lacking Stat1, we have observed a positive
correlation between G-CSF expression levels and the absolute
number of neutrophils infiltrating the lungs after CD8+ T-cell
transfer (unpublished observation). We also observed a reduction
in many pro- and anti-inflammatory cytokines in recipients of
ADAM172/2 CD8+ T cells compared to WT cells, including IL1b, IL-5, IL-6, IL-9, IL-10, IL-13, IL-15, LIF, and M-CSF (data
not shown). Thus, defective TNF-a processing by ADAM172/2
CD8+ T cells diminishes the expression of lung epithelial cellderived chemokines and the subsequent reduction in inflammatory
airway infiltration.

exacerbates lung injury by enhancing macrophage and neutrophil
infiltration of the airways.

Expression of ADAM17 on CD8+ T cells is required for
enhanced pulmonary inflammation
With a significant decrease in pulmonary infiltration of
ADAM172/2 CD8+ T-cell recipients, we next wanted to examine
the impact, which ADAM17-deficiency on transferred HA-specific
CD8+ T cells had on lung epithelial cell chemokine expression. We
prepared cell-free BAL fluid from SPC-HA transgenic mice 24
hours after HA-specific CD8+ T-cell transfer and measured the
expression of cytokines and chemokines in the airways by Luminex
assay. We observed significant differences in a variety of
proinflammatory mediators with a general trend for reduced
airway inflammation in recipients of ADAM172/2 CD8+ T cells.
Consistent with the decreased expression of CXCL2 observed in
the lungs of tmTNF CD8+ T-cell recipients (Figure 2F), there was
a reduction in the levels of CXCL2 in the airways of ADAM172/2
CD8+ T-cell recipients (Figure 8A). This strongly indicates that
proteolytic processing of TNF-a is required for lung epithelial cell
production of CXCL2. Moreover, there was a reduction in the
levels of CCL2 in ADAM172/2 CD8+ T-cell recipients (Figure
8B). There was also a significant reduction in expression of IP-10
and CCL11 (eotaxin), chemoattractant proteins for lymphocytes
and eosinophils, respectively, in recipients of ADAM172/2 CD8+
T cells (Figures 8C, 8D). This is consistent with the observed
reduction in mRNA expression of both IP-10 and CCL11 in
PLOS ONE | www.plosone.org

Discussion
In this study, we characterized the roles of CD8+ T-cell
expressed tmTNF-a and sTNF-a in the SPC-HA transgenic
mouse model of CD8+ T-cell mediated immunopathology in
8
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Figure 6. CD8+ T-cell expression of ADAM17 is required for TNF-a processing following antigen recognition in vivo. SPC-HA transgenic
mice received 107 WT or ADAM172/2 HA-specific CD8+ T cells via tail vein injection. ELISA was used to assess (A) TNF-a and (B) IFN-c expression in
cell-free BAL fluid. Alternatively, HA-specific CD8+ T cells were labeled with CFSE prior to transfer. Twenty-four hours after transfer, cells were
recovered from (C) BAL and (D) lung homogenates and assessed by flow cytometric analysis to determine the total number of transferred HA-specific
CD8+ T cells present. Data represent mean 6 standard deviation. Data are representative of two or more independent experiments with 4 mice per
group. **P,0.01.
doi:10.1371/journal.pone.0079340.g006

pathology associated with highly pathogenic influenza viruses.
Here we show in the absence of replicating virus or innate
responses, that production of sTNF-a by HA-specific CD8+ T cells
enhanced the expression of a variety of proinflammatory cytokines
and chemokines. Humans infected with the highly pathogenic
H5N1 influenza virus, exhibited high serum levels of CCL2,
CXCL9 and IP-10, especially in lethal cases [28]. Blockade of HAspecific CD8+ T-cell TNF-a processing diminished expression of
these chemokines in the airways of SPC-HA transgenic mice.
Furthermore, in mice infected with influenza virus expressing the
HA and neuraminidase of the highly pathogenic 1918 H1N1
influenza virus, CCL2, CXCL2, IL-6 and G-CSF were found to
be significantly elevated in the lungs [29]. In SPC-HA transgenic
mice receiving ADAM172/2 CD8+ T cells, the expression of these
inflammatory mediators was significantly diminished. This suggests that sTNF-a production by CD8+ T cells might function to
enhance the expression of pro-inflammatory mediators and
exacerbate disease during highly pathogenic influenza infection.
Elevated levels of inflammatory mediators leading to the
subsequent enhanced pulmonary infiltration as the main driver
of influenza immunopathology is supported by the injury initiated
by CD8+ T cells in this model, as diffuse alveolar damage is
significantly dependent upon lung epithelial cell chemokine
expression and the resulting host cellular airway infiltration. We
found a direct requirement for processing of TNF-a by HAspecific CD8+ T cells in the induction of lung epithelial cell
expression of CXCL2, as the level of this chemokine was
reduced when CD8+ T-cell processing of TNF-a was inhibited.

influenza infection. The model has been designed to isolate
specifically the contribution of CD8+ T-cell-mediated injury
without the complication of viral cytopathology. We identified
ADAM17 as the protease responsible for proteolytic processing of
TNF-a on CD8+ T cells. Moreover, we observed that proteolytic
processing of tmTNF-a by HA-specific CD8+ T cells to release
sTNF-a was required to initiate severe and lethal lung injury in
SPC-HA transgenic mice. Transfer of CD8+ T cells expressing
only the non-cleavable tmTNF-a or lacking ADAM17 activity
resulted in attenuated cellular infiltration and significantly milder
lung injury. The reduced cellular infiltration observed in the
absence of sTNF-a was due in part to the inability of CD8+ T-cell
expression of tmTNF-a to induce lung epithelial cell chemokines
such as CXCL2. We further confirmed the importance of lung
epithelial cell expression of CXCL2 by transferring HA-specific
CD8+ T cells into CXCR2-deficient SPC-HA-transgenic mice.
Abrogation of CXCR2 signaling resulted in reduced airway
cellular infiltration, limited impact on tissue integrity, and
enhanced survival. Taken together, our study is the first to
identify a critical role for ADAM17-dependent processing of TNFa by CD8+ T cells in T-cell-mediated immunopathology.
As influenza HA antigen expression is widespread throughout
the alveolar airspace of the SPC-HA transgenic mouse, we believe
this represents a clinically challenging circumstance similar to that
observed during highly pathogenic influenza virus infection, with
distal airway tropism, large antigen load, and robust interference
with innate immune responses. Moreover, dysregulated cytokine
and chemokine expression is thought to play a role in the severe
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Figure 7. ADAM17 expression on transferred CD8+ T cells is required for enhanced airway infiltration. SPC-HA transgenic mice received
107 WT or ADAM172/2 HA-specific CD8+ T cells via tail vein injection. (A) On the days indicated, cells were recovered from BAL and counted on a
hemocytometer with trypan blue exclusion to determine the total number of viable cells. Percentage of (B) macrophages and (D) neutrophils was
determined by morphological analysis of cells after staining cytospin preparations. Absolute number of (C) macrophages and (E) neutrophils was
calculated by multiplying the percent of cells by the total number of cells recovered from BAL. Data represent mean 6 standard deviation. Data are
representative of two or more independent experiments with 3-4 mice per group. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0079340.g007

Furthermore, a principal role for CXCL2 in mediating lung injury
was demonstrated by the observation that SPC-HA transgenic
mice lacking CXCR2 displayed milder lung injury and improved
survival after HA-specific CD8+ T-cell transfer. Other studies in
mice lacking CXCR2 or CCR2, the primary receptor of CCL2,
have shown that blockade of chemokine signaling reduces
pulmonary recruitment and subsequently reduces injury and

PLOS ONE | www.plosone.org

improves survival following influenza infection [30,31]. In our
model, processing of TNF-a by HA-specific CD8+ T cells is
required for the enhanced recruitment of inflammatory cells to the
lung, since inhibition of TNF-a processing only by the transferred
CD8+ T cells significantly reduced the number of cells recruited to
the airways. Though other cells, such as macrophages (which
accumulate after initial antigen recognition by T cells) are capable
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Figure 8. ADAM17 expression on transferred CD8+ T cells is required for enhanced airway inflammation. SPC-HA transgenic mice
received 107 WT or ADAM172/2 HA-specific CD8+ T cells via tail vein injection. Twenty-four hours after T-cell transfer, cell-free BAL fluid was prepared
and the levels of (A) CXCL2, (B) CCL2, (C) IP-10, (D) CCL11, (E) CXCL5, and (F) G-CSF were determined by Luminex assay. Data represent mean 6
standard deviation. Data are representative of two mice from two independent experiments with a total of 4 mice per group. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0079340.g008

response [7]. Furthermore, we found that CD8+ T-cell-specific
inhibition of TNF-a processing did not impair host protection
against influenza virus as influenza-specific ADAM172/2 CD8+ T
cells were able to provide complete protection against an otherwise
lethal viral challenge. This suggests that inhibition of TNF-a
processing may also lessen disease severity without compromising
the immune response against the virus, and introduces a new
target to limit pulmonary pathology during influenza infection.
Antibody neutralization of TNF-a during influenza infection has
revealed that it is possible to reduce pulmonary infiltration and
pathology and improve survival without impairing virus clearance
[33,34]. Importantly however, TNF-a has been shown to play a
role in protection against secondary bacterial pneumonia after
influenza infection and anti-TNF-a therapies, which target both
tmTNF-a and sTNF-a, have been associated with an increased
risk for bacterial infection [35-37]. Therefore, it may be

of producing sTNF-a, the enhanced appearance of epithelial cell
chemokines after transfer of WT CD8+ T cells likely results from
the very early expression of sTNF-a in the hours following T-cell
receptor engagement. This correlates with the early neutrophil
influx observed during the first 48 hours after CD8+ T-cell
transfer, which may set the stage for enhanced lung injury by
proteolytic degradation of the basement membrane, oxidative
injury of endothelial and epithelial cells, and/or production of
inflammatory mediators themselves. A recent report describes
early neutrophil recruitment as driving a "feed-forward" amplification of inflammation and injury in lethal influenza infection
[32].
We showed previously that CD8+ T-cell-specific TNF-adeficiency does not impair either virus clearance or immune
protection against an otherwise lethal influenza infection, indicating that TNF-a neutralization may not compromise the antiviral
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deleterious to neutralize both tmTNF-a and sTNF-a during
influenza infection.
There are at least two methods in which the deleterious effects
of sTNF-a can be inhibited while sparing the immuno-protective
effects of tmTNF-a. The first is a class of dominant negative antiTNF-a biological agents that selectively bind to and inhibit only
sTNF-a without impairing tmTNF-a function [18]. These agents
would not inhibit the proteolytic processing and release of sTNF-a
by virus-specific CD8+ T cells, but it would block the actions of
sTNF-a and may attenuate lung injury mediated by sTNF-a. An
alternative approach to selectively inhibiting the actions of sTNF-a
while sparing tmTNF-a might be the use of ADAM17 inhibitors,
which would inhibit the proteolytic processing of TNF-a. Other
studies have confirmed a role for ADAM17-dependent processing
of TNF-a in acute lung injury suggesting that ADAM17 may also
represent a potential therapeutic target [21,22]. Selective inhibitors of ADAM17 have been developed, but have failed to show
efficacy in treatment of rheumatoid arthritis [38]. However, two
independent studies using endotoxin-triggered models of acute
lung injury in mice found that intranasal delivery of selective or
partially selective ADAM17 inhibitors blocked sTNF-a release and
reduced vascular permeability and influx of neutrophils into the

airways [22,39]. This suggests that transient and targeted delivery
of ADAM17 inhibitors can mitigate tissue injury with minimal side
effects.
In conclusion, we demonstrate that ADAM17-mediated processing of tmTNF-a to sTNF-a is a critical event in CD8+ T cellmediated lung injury. CD8+ T-cell-specific inhibition of ADAM17-mediated processing of TNF-a resulted in decreased
chemokine production by alveolar epithelial cells and reduced
cellular infiltration of the airways, attenuating tissue injury and
mortality in a transgenic mouse model of influenza pneumonia. It
remains to be seen whether differential expression patterns of
tmTNF-a and sTNF-a by CD8+ T cells have distinct or
overlapping biological functions during influenza infection and
whether inhibition of ADAM17 processing of TNF-a or specific
inhibition of sTNF-a can attenuate lung injury during severe
influenza infection.
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